Anti-Cancer Drugs Journal Issues Research Articles in March 2023 Edition
March 07, 2023
March 07, 2023
LONDON, England, March 7 -- Anti-Cancer Drugs, a journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles on the following topics in its March 2023 edition:
Preclinical Reports:
* Exosomal circ-ADRM1 promotes lung adenocarcinoma progression and induces macrophag . . .
Preclinical Reports:
* Exosomal circ-ADRM1 promotes lung adenocarcinoma progression and induces macrophag . . .